COH share price in focus
Cochlear, established in 1981 in Sydney, is a leading medical device company specializing in hearing solutions. The company designs, manufactures, and distributes three types of hearing implants tailored to various medical needs.
As a global leader in hearing technology, Cochlear has delivered over 750,000 implantable devices and employs more than 5,000 people across 50+ countries.
Its mission is to enhance the quality of life for individuals living with hearing-related conditions.
JBH shares
Established in 1974, JB Hi-Fi is one of Australia’s largest retailers of electronic and home entertainment products.
The company is broadly split into three business segments, namely JB Hi-Fi Australia, JB Hi-Fi New Zealand and The Good Guys, which sells a similar range of products and was acquired in 2016.
JB Hi-Fi operates through a cost-leadership strategy meaning it competes on price against its competitors. Many of its products are often discounted resulting in much better perceived value for its customers.
COH & JBH share price valuation
As a growth company, some of the trends we might investigate from COH include revenue growth, profit growth, and return on equity (ROE). These measures can indicate the growth rates and prospects of the company, as well as their ability to generate returns from their assets.
Since 2021, COH has grown revenue at a rate of 14.3% per year to reach $2,236m in FY24. Over the same stretch of time, net profit has increased from $324m to $357m. As for ROE, COH last reported a ROE of 19.9%.
Over the last 3 years, JBH has increased revenue at a rate of 2.5% per year to hit $9,592m in FY24. Meanwhile, net profit has fallen from $506m to $439m. As for ROE, JBH’s last reported figure was 29.5%.
Please keep in mind that context is important. These metrics give us some indication of company performance, but it’s just the start of valuing COH or JBH shares. To learn more about valuation, check out one of our free online investing courses.
